Login / Signup

Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic.

Jason D Goldman
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • phase iii
  • study protocol
  • phase ii
  • clinical trial